SCHEMBL370736

SCHEMBL370736

Cc1cc(F)ccc1[C@@H](CC(=NO)c1ccc(=O)n(C)c1)c1ccc(Br)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 5/20 0.51
EGFR P00533 2/20 0.35
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
ALDH1A1 P00352 4/20 0.31
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
BRD4 O60885 1/20 0.30
FFAR1 O14842 1/20 0.30
LMNA P02545 2/20 0.30
HPGD P15428 1/20 0.30
HTT P42858 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C19 P33261 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368988 1.00 GPBAR1 (0.51) GPBAR1EGFRKEAP1NFE2L2ALDH1A1
SCHEMBL369048 1.00 GPBAR1 (0.51) GPBAR1EGFRKEAP1NFE2L2ALDH1A1
SCHEMBL370735 1.00 GPBAR1 (0.51) GPBAR1EGFRKEAP1NFE2L2ALDH1A1
SCHEMBL369047 1.00 GPBAR1 (0.51) GPBAR1EGFRKEAP1NFE2L2ALDH1A1
SCHEMBL369611 1.00 GPBAR1 (0.51) GPBAR1EGFRKEAP1NFE2L2ALDH1A1
SCHEMBL368987 1.00 GPBAR1 (0.51) GPBAR1EGFRKEAP1NFE2L2ALDH1A1
SCHEMBL369685 0.91 GPBAR1 (0.45) GPBAR1EGFRKEAP1NFE2L2ALDH1A1
SCHEMBL369684 0.91 GPBAR1 (0.45) GPBAR1EGFRKEAP1NFE2L2ALDH1A1
SCHEMBL368135 0.90 GPBAR1 (0.44) GPBAR1EGFRKMT2A
SCHEMBL368136 0.90 GPBAR1 (0.44) GPBAR1EGFRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP claimed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO claimed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885EGFR 2863/4885KEAP1 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.